Mode
Text Size
Log in / Sign up
N/A Completed N=35 Single-blind Treatment

Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks

Source: ClinicalTrials.gov NCT02670473 ↗
Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Lens Fit - Centration — 88; 97; 99; 100 percentage of eyes

Summary

The aim of this dispensing study is to evaluate the clinical performance of habitual wearers of enfilcon A lenses following a refit with fanfilcon A lenses over 4 weeks of daily wear.

Outcome Measures

OutcomeResultp-value
PRIMARY
Lens Fit - Centration
88; 97; 99; 100; 12; 3 —
PRIMARY
Lens Fit - Post-blink Movement
0; 0; 0; 0; 1; 1 —
PRIMARY
Lens Tightness on Push-up
50; 49; 50; 50 —
PRIMARY
Overall Fit Acceptance
0; 0; 0; 0; 0; 0 —
SECONDARY
Overall Comfort
8.03; 8.91; 8.97; 8.85 —
SECONDARY
Dryness Overall
7.88; 8.82; 8.85; 8.82 —
SECONDARY
Handling
8.85; 9.26; 9.59; 9.62 —
SECONDARY
Overall Vision Satisfaction
9.24; 9.56; 9.79; 9.74 —
SECONDARY
Overall Satisfaction
26; 71; 3; 0; 53; 47 —
SECONDARY
Lens Preference Overall
18; 82; 6; 94; 6; 94 —
SECONDARY
Wearing Times
8.79; 9.82; 9.65; 9.85; 7.65; 8.97 —
SECONDARY
Conjunctival Staining
100; 97; 99; 94; 0; 3 —
SECONDARY
Corneal Staining
100; 100; 100; 100; 0; 0 —

Eligibility Criteria

Inclusion criteria

A person is eligible for inclusion in the study if he/she:

  • Is between 18 and 40 years of age
  • Has had a self-reported visual exam in the last two years
  • Is an adapted enfilcon A contact lens wearer (at least 2 weeks in enfilcon A lens)
  • Has a contact lens spherical prescription between -1.00 to - 6.00
  • Has a spectacle cylinder up to 0.75D (Diopters) in each eye.
  • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
  • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
  • Has clear corneas and no active ocular disease
  • Has read, understood, and signed the information consent letter.
  • Patient contact lens refraction should fit within the available parameters of the study lenses.
  • Is willing to comply with the wear schedule (at least 5 days per week, > 8 hours/day assuming there are no contraindications for doing so).
  • Is willing to comply with the visit schedule

Exclusion Criteria

A person will be excluded from the study if he/she:

  • Is not a habitual wearer of enfilcon A lenses
  • Has a CL (Contact Lens) prescription outside the range of the available parameters of the study lenses.
  • Has a spectacle cylinder ≥1.00D of cylinder in either eye.
  • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
  • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
  • Presence of clinically significant (grade 3-4) anterior segment abnormalities
  • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
  • Slit lamp findings that would contraindicate contact lens wear such as:
  • Pathological dry eye or associated findings
  • Pterygium, pinguecula, or corneal scars within the visual axis
  • Neovascularization > 0.75 mm in from of the limbus
  • Giant papillary conjunctivitis (GCP) worse than grade 1
  • Anterior uveitis or iritis (past or present)
  • Seborrheic eczema, Seborrheic conjunctivitis
  • History of corneal ulcers or fungal infections
  • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
  • Has aphakia, keratoconus or a highly irregular cornea.
  • Has Presbyopia or has dependence on spectacles for near work over the contact lenses.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02670473). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search